Starting this spring, we will be participating in a study to evaluate the Canine Osteosarcoma Vaccine, Live Listeria Vector (COV - LLV), a conditionally licensed product
for dogs with osteosarcoma who have undergone amputation and chemotherapy.
Not exact matches
Of the
dogs stricken
with osteosarcoma, 35 had the cancer in a leg which was subsequently amputated, followed by chemotherapy, which is the standard - of - care treatment; the
dogs with elevated total cholesterol had a median survival time of 455 days, more than 200 days greater than the median survival time
for dogs with normal cholesterol.
Starting in 2007,
for example, Fan began testing an anti-cancer drug called PAC - 1 (developed by U. of I. chemistry professor Paul Hergenrother) in pet
dogs with naturally occurring lymphomas and
osteosarcomas.
The treatment of choice by veterinarians
for most
dogs with osteosarcoma of the leg is amputation of the affected limb, after which most
dogs do function quite well.
Purpose of Study: Standard therapy
for dogs diagnosed
with osteosarcoma has long been amputation of the affected limb followed by chemotherapy to prevent the spread of cancer.
«In order to be eligible
for the study, a
dog with osteosarcoma must have the primary tumor removed and undergo chemotherapy.»
Because of this, systemic chemotherapy is recommended as follow - up therapy
for dogs with appendicular
osteosarcoma.
The Ohio State CTO is also continuing to partner
with Nationwide Children's Hospital to study bone cancer (
osteosarcoma) in both
dogs and children
with the hope of finding better treatments
for this devastating disease.
Most
dogs with osteosarcoma that undergo amputation and chemotherapy, just like «Layla,» only live
for about a year.